Vickram V. Anand

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trials.

Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trials.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: August 18, 2025

Long-term prognosis of coexistent metabolic dysfunction-associated steatotic liver disease and chronic kidney disease following acute myocardial infarction.

Long-term prognosis of coexistent metabolic dysfunction-associated steatotic liver disease and chronic kidney disease following acute myocardial infarction.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 18, 2025

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.

Journal: Cardiovascular diabetology

Published: March 15, 2025

Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study.

Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study.

Journal: Diabetes, obesity & metabolism

Published: August 30, 2024

Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.

Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: July 18, 2024

Global burden of cardiovascular diseases: projections from 2025 to 2050.

Global burden of cardiovascular diseases: projections from 2025 to 2050.

Journal: European journal of preventive cardiology

Published: June 11, 2024

The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.

The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.

Journal: The Lancet regional health. Western Pacific

Published: May 09, 2024

The Global Epidemic of Metabolic Fatty Liver Disease.

The Global Epidemic of Metabolic Fatty Liver Disease.

Journal: Current cardiology reports

Published: January 22, 2024

General Public's knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population.

General Public's knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population.

Journal: Frontiers in medicine

Published: March 25, 2023

Cardiovascular Outcomes in Acute Coronary Syndrome and Malnutrition: A Meta-Analysis of Nutritional Assessment Tools.

Cardiovascular Outcomes in Acute Coronary Syndrome and Malnutrition: A Meta-Analysis of Nutritional Assessment Tools.

Journal: JACC. Advances

Published: February 06, 2023

Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: A meta-analysis using multidimensional socioeconomic status indices.

Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: A meta-analysis using multidimensional socioeconomic status indices.

Journal: International journal of cardiology

Published: January 02, 2023

Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.

Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.

Journal: International journal of obesity (2005)

Published: December 30, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026